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Abstrak 
 Hematoma subdural kronik (CSDH) menjadi salah satu diagnosis yang paling kerap 
dalam amalan neurosurgeri. Dengan penuaan penduduk terutamanya di negara-negara yang 
maju dan membangun, kejadian CSDHs dijangka semakin meningkat. Kraniostomi “burr-
hole”, irrigasi dan penempatan satu system saliran dalaman adalah pembedahan semasa 
disyorkan untuk CSDH. Tujuan kajian ini adalah untuk membuat satu perbandingan antara 
dua teknik pembedahan dalam rawatan CSDH, yang telah terbukti dalam kajian sebelum ini. 
Objektif utama kami adalah untuk membandingkan keberkesanan penempatan “subperiosteal 
drain” (SPD) dan “subdural drain” (SDD) berikutan burr-hole dan irrigasi, dan juga untuk 
mengkaji perbezaan yang signifikan dari segi komplikasi pembedahan, hasil fungsi pada 3 
bulan dan kadar kematian. Kajian ini telah dijalankan di dua pusat neurosurgeri tempatan, di 
mana kumpulan SPD yang telah dijalankan di Hospital Umum Sarawak (HUS) dan kumpulan 
SDD yang telah dilakukan di Hospital Sultanah Aminah Johor Bahru. Kajian kami 
menjangkau tempoh 2 tahun dengan data 30 pesakit bagi kedua-dua kumpulan. Secara 
keseluruhannya, tidak terdapat perbezaan statistik yang signifikan dari segi ciri-ciri pesakit 
umum, gejala pra-pembedahan dan selepas pembedahan, gred Markwalder, baki isipadu 
hematoma selepas pembedahan dan berulang, kematian dan hasil fungsian selepas 
pembedahan dan pada 3 bulan susulan antara kedua-dua kumpulan pesakit. Walaupun tidak 
mencapai kepentingan statistik, kami memerhatikan kadar yang lebih rendah dari segi 
komplikasi pembedahan terutamanya dalam aspek pendarahan otak (intracranial hematoma) 
selepas pembedahan dengan penempatan sistem SPD. Kajian ini menyimpulkan bahawa 
rawatan dengan “burr-hole”, irigasi dan penempatan sistem SPD adalah sama berkesan untuk 
sistem SDD dengan kadar yang lebih rendah secara keseluruhan dari segi komplikasi 
pembedahan untuk CSDHs. 
 
Abstract 
 
Symptomatic chronic subdural hematomas (CSDH) remain one of the most frequent 
diagnoses in current neurosurgical practice. With the aging population especially in the well-
developed and developing countries, the incidence of CSDHs is expected to steadily witness 
an exponential rise. Burr-hole craniostomy with irrigation and placement of a close-system 
drainage is the current recommended surgery for symptomatic CSDH. The aim of this study 
is to perform a direct comparison between two surgical techniques in the treatment of 
symptomatic CSDH, which have been proven in previous studies to be efficient. Our main 
objective was to compare the efficacy of placement of a subperiosteal drain (SPD) and a 
subdural drain (SDD) following single burr-hole craniostomy and irrigation, and also to 
demonstrate any significant differences in terms of overall surgical complications, functional 
outcome at 3 months and mortality rate. The study was carried out in two well established 
local neurosurgical centres, whereby the SPD group was performed in Hospital Umum 
Sarawak (HUS) and the SDD group was performed in Hospital Sultanah Aminah Johor 
Bahru. Our study spanned over a duration of 2 years with data of 30 patients for both groups 
colleted and analyzed. Overall, there were no statistically significant difference in terms of 
patient general characteristics, pre-operative and post-operative symptoms, Markwalder 
grades on admission and at discharge, post-operative hematoma volume and recurrence, 
mortality and functional outcome at discharge and at 3 month follow-up between both groups 
of patients. Although not achieving statistical significance, we observed a lower rate of 
surgical complication especially for post-operative intracranial hematoma with placement of 
the SPD system. This study concludes that treatment with single burr-hole craniostomy, 
irrigation and placement of SPD system is equally effective to the SDD system with a lower 
overall surgical complication rate for CSDHs.  
SUBPERIOSTEAL DRAINAGE VERSUS SUBDURAL DRAINAGE IN THE 
MANAGEMENT OF CHRONIC SUBDURAL HEMATOMA (A COMPARATIVE 
STUDY) 
 
Dr Adrian Ng Wei Chih 
MSurg Neurosurgery 
 
Department of Neurosciences 
School of Medical Sciences, University Sains Malaysia 
Health Campus, 16150 Kelantan, Malaysia 
 
Introduction: Symptomatic chronic subdural hematomas (CSDH) remain one of the 
most frequent diagnoses in current neurosurgical practice. Burr-hole craniostomy with 
irrigation and placement of close-system drainage is the current recommended surgery for 
symptomatic CSDH. The aim of this study is to perform a direct comparison between two 
surgical techniques in the treatment of symptomatic CSDH, which have been proven in 
previous studies to be efficient. Our main objective was to compare the efficacy of placement 
of a subperiosteal drain (SPD) and a subdural drain (SDD) following single burr-hole 
craniostomy and irrigation, and to demonstrate any significant differences in terms of overall 
surgical complications, functional outcome at 3 months and mortality rate. 
 
 Objectives:  The aims of this study was to perform a direct comparison on the 
efficacy of placement of the subperiosteal drain and subdural drain in the treatment of 
symptomatic CSDH, and to evaluate any differences in terms of overall surgical 
complications, functional outcome and mortality.  
 
Materials and Methods: The study was carried out in two local neurosurgical 
centres. The SPD group was performed in Hospital Umum Sarawak (HUS) and the SDD 
group was performed in Hospital Sultanah Aminah Johor Bahru (HSAJB), from 1st January 
2012 till 30th January 2014 with a total of 30 patients in both treatment groups. 
 
Results: Overall, there were no statistically significant difference in terms of patient 
general characteristics, pre-operative and post-operative symptoms, Markwalder grades, post-
operative hematoma volume and recurrence, mortality and functional outcome at discharge 
and at 3 month follow-up between both groups. Albeit not achieving statistical significance, 
we observed a lower rate of surgical complication especially for post-operative intracranial 
hematoma with placement of the SPD system. 
 
Conclusion: Our study concludes that both treatment methods proved to be highly 
effective in the treatment of CSDH. However, with a lower overall surgical complication rate, 
treatment with single burr-hole craniostomy, irrigation and placement of the SPD system can 
be considered a treatment of choice for the management of symptomatic CSDH. 
 
Dr. (Mr.) Badrisyah Idris: Supervisor 
Dr. (Mr.) Albert Wong Sii Hieng: Co-Supervisor 
Dr. (Mr.) Noor Azman: Co-Supervisor 
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CHAPTER 1 
 
Introduction 
Chronic subdural hematoma (CSDH) is defined as a slow growing encapsulated 
collection of blood and its breakdown product within the subdural layer of the dura mater. 
(Chen et al. 2000). The term chronic encompasses a period of 2 weeks or more, usually with 
most patients recalling some form of prior head injury which leads to traumatic tearing of 
bridging veins connecting the brain parenchymal surfaces with the dura mater.  
 
Epidemiologically, CSDH is one of the most common forms of intracranial 
hemorrhage encountered in daily neurosurgical practice. At present, its incidence is on the 
rise due to the prolonged life expectancy of the general population in developing countries in 
recent years. On average, its incidence is estimated to be between 1 and 5 cases per 100,000 
people (Kudo et. al 1992, Gazerri et. al 2007). CSDH is more common among the elderly, 
with reported incidences of up to 7.5 cases per 100,000 people, rising up to 58 per 100,000 
people in patients above 65 years of age (Mellegard et al. 1996, van Havenbergh et. al 1996, 
Gazerri et. al 2007). These numbers are expected to double in the next two decades by the 
year 2030 as the general population continues to mature in age (Santarius et. al 2010). In a 
larger demographic study conducted by Baechli and colleagues in 2004, they reported a 
significantly higher prevalence of CSDH in patients older than 65 years (69% vs. 31%), and 
that men are more frequently affected women (64% vs. 33%). The higher incidence of CSDH 
in men is most likely a result of over-representation of head injury in the male counterparts. 
In addition, between 20-25% of the CSDH cases, patients present with bilateral lesions 
(Greenberg MS, 2010).  
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As mentioned earlier, the elderly population are at a higher risk of developing CSDH, 
whereby age related cerebral atrophy with a corresponding increase in subdural space 
predisposes the increasingly fragile bridging veins to stretching and tearing. This additional 
subdural space volume can be occupied by the hematoma before considerable rise in 
intracranial pressure occurs, hence the typical delayed presentation of usually 1-2 weeks later. 
Trivial head injuries or repeated falls prior to clinical presentation are a common antecedent 
event described in most elderly patients. In their study in 2004, Baechli et. al also noted that 
in 77% of the cases, the patient had a prior fall in the past and 41% of the patients had 
underlying medical co-morbid conditions requiring treatment with oral anti-coagulants or 
platelet aggregation inhibitors. The risk of developing a CSDH was at least 42.5 times higher 
in warfarinised patients and also increased for patients on aspirin (Rust et. al 2006). Other 
common risk factors associated with an increased risk of CSDH are chronic alcohol 
consumption, chronic liver and renal impairment, epilepsy, and diabetes mellitus. In a study 
from Helsinki, chronic alcohol consumption was reported in 50% of the patients with CSDH 
(Fogelholm R et. al 1975). This was related to factors such as alcohol-induced liver 
impairment, platelets dysfunction, and alcohol-related cerebral atrophy.   
 
There has been an ongoing debate on the actual pathophysiology of CSDH, and 
consequently its evolution and recurrence, all of which has bearing in the general 
management of CSDH. The pathophysiology of CSDH was first theorized by Virchow back 
in 1857, when he coined the term “pachymeningitis hemorrhagica interna” which recognized 
the presence of dural inflammation and hemorrhagic elements. By the early 20th century, the 
traumatic nature of CSDH was established and widely accepted and with the advent of ultra-
structural study of subdural membranes, the complex pathophysiology of CSDH since been 
put forth. Current evidence suggests that the formation and evolution of CSDH is 
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multifactorial. Many theories have been reported, which includes the “micro-bleed” theory, 
the “inflammatory and growth factor” theory, and the “anti-coagulant and profibrinolytic” 
theory.  
 
Figure 1.0 Diagram depicting the ultra-structural architect of the meninges (adapted from 
Santarius et al. 2010). The dura mater is largely composed of fibroblast and collagen. The 
arachnoid layer is supported by a basement membrane held together with numerous tight 
junctions (red diamonds). The dural border cells (green layer) are composed of fibroblasts 
without tight junctions and are a relatively loose layer in between the firm dura mater and 
arachnoid mater. Therefore, the subdural space is indeed a potential space that can form 
within the dural border cell layer (green). The bridging veins (blue round spheres) act as a 
potential source of bleeding within this layer.  
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As depicted in Figure 1.0, the layer of dural border cells is comprised of cells devoid 
of tight junctions and enlarged extracellular space containing amorphous material (Santarius 
et al 2010). It is this layer of dura border cells that tethers the dura and arachnoid layer 
together, which makes the subdural space virtually non-existent in healthy individuals. With 
age and the increasing cerebral atrophy along with it, the arachnoid layer is gradually 
stretched away from the dural layer, which remains adhered to the skull bone. The resultant 
force pulls the dural border cell layer and stretches the traversing bridging veins. Hence, any 
additional force can result in tearing of these veins with subsequent bleeding into the dural 
border cell, thus creating a relatively minor acute subdural hematoma. Today, it is widely 
accepted that the initial trauma and development of the CSDH occurs as a result of a cascade 
of inflammatory process triggered by the presence of blood. After approximately 2 weeks, an 
inner (pial) and outer (dural) neo-membrane is formed inside the dural border cell layer 
through collagen synthesis and fibroblast spread (Ducreut et. al 2012, Drapkin 1991). The 
subsequent neovascularization and formation of fragile capillaries into the neo-membranes of 
the hematoma capsule lead to further micro-bleeds within the subdural space. This was due to 
the lack of muscle layer in these neo-capillaries, making them fragile and susceptible to 
repeated micro-bleeding and consequent CSDH expansion (Ducreut et. al 2012). In a report 
by Weigel R et. al in 2001, they theorized that the ongoing inflammation causes high levels 
of vascular endothelial growth factors (VEGF) within the CSDH. This leads to enhanced 
angiogenesis and hyperpermeability of the neo-capillaries which directly contributes to 
hematoma expansion. The neomembranes of the CSDH capsule also demonstrate high 
concentrations of profibrinolytic and anticoagulation factors, which prevent hemostasis and 
enhance further expansion of the hematoma (Labadie et. al 1975). In addition, the presence of 
high levels of tissue plasminogen activator (TPA) and high fibrin degradation products within 
the CSDH also negates hemostasis and contributes to hematoma growth (Katano et. al 2006).  
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 The clinical presentation of CSDH varies widely without any pathognomonic 
symptoms or signs. Furthermore, the development of these symptoms is usually slow and 
progressive over time in the majority of patients as the preceding head injury tends to be 
trivial without any accompanying severe brain injury. With slow accumulation of blood and 
under relatively low pressure, the time from onset to presentation can range from weeks to 
months. Therefore, patients with CSDH can be asymptomatic, present with subtle symptoms 
such as headache, altered sensorium, vomiting and giddiness or present with more severe life 
threatening symptoms secondary to increasing intracranial pressure such as seizures, 
hemiparesis or coma. As such, a clinical grading system was devised by Markwalder in 1981, 
to aid in the objective assessment of patients presenting CSDH. It is as shown in Table 1.0 
below. This grading system is used pre- and post-operatively to assess the clinical course of 
the patient. 
 
Table 1.0: Markwalder grading scale for CSDH 
 
Grade 0 
 
No neurological symptoms or signs 
Grade 1 
 
Headache, Asymmetrical reflexes 
Grade 2 
 
Altered mental status, Hemiparesis 
Grade 3 
 
Stupor but responsive, Hemiplegia 
Grade 4 
 
Coma, Decrebrate/Decorticate posturing 
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Clinically, CSDH is defined as a hematoma that has persisted more than 21 days after 
trauma, giving rise to an appearance of dark red liquefied blood surrounded by a thin capsular 
membrane observed intraoperatively. Other descriptive terms of the CSDH consistency is of 
the classic “crankcase-oil” appearance upon surgical evacuation. The older classification of 
subdural hematomas is based on the density appearance on computed tomography (CT) 
scans. However, this previous CT characterization of acute SDH as hyperdense, subacute 
SDH as isodense and chronic SDH being hypodense is no longer of clinical significance. 
Until recently, Nakaguchi et. al in 2001 described a newer radiological classification of 
CSDH which provided a significant influence on the risk of recurrence in the post-operative 
period. They classified radiological appearance of CSDH into 4 main types: homogenous, 
laminar, and separated and trabeculated, based on the internal architecture and natural history 
of CSDH. 
 
Figure 2.0 Non-contrast computed tomography (NCCT) scans showing classification of 
CSDH according to their internal architectures (adapted from Nakaguchi et.al 2001). Upper 
left: Homogenous type. Upper right: Laminar type. Bottom left: Separated type. Bottom right: 
Trabeculated type. 
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The Nakaguchi classification serves as an independent predictor of recurrence in 
patients with CSDH based on the internal architectural appearance on NCCT scans, as shown 
in Table 2.0. Both the homogenous and trabeculated type showed lower risk of post-operative 
recurrence rate as compared with the laminar and separated types.  
 
Table 2.0 Post-operative risk of recurrence based on the Nakaguchi classification of CSDH 
Hematoma type 
 
Risk of Post-operative Recurrence (%) 
Homogenous stage 10-15%  
Laminar stage 20% 
Separated stage 40% 
Trabeculated 0% 
 
 
 Therapeutic options for patients with CSDH include non-surgical or surgical 
management by means of burr-hole craniostomy, twist drill craniostomy or craniotomy. 
Asymptomatic patients without radiological evidence of mass effect are usually managed 
expectantly with serial follow-ups and repeat NCCT scans. There is no recommended cut-off 
size of the CSDH seen on NCCT scans to determine surgery for patients. Furthermore, 
spontaneous resolution of CSDH have been reported in elderly patients (>70 years) who are 
asymptomatic (Parlato et. al 2000, Goksu et. al 2009). However, Naganuma and colleagues in 
1986 reported that spontaneous resolution rarely occurs in CSDH patients and advocate 
surgical evacuation.  
 
8 
 
The decision for surgical evacuation of a CSDH is also influenced by both the clinical 
presentation of the patient as well as the radiographic appearance of the lesion. Surgery is 
indicated for any patient who demonstrates neurological symptoms (Baechli H et. al 2004, 
Camel M et. al 1986). The technique of both a single or double burr-hole followed by a 
closed drainage system has been proven to be safe, cost-effective, and associated with 
reduced morbidity and mortality (Belkhair et. al 2013, Han et. al 2009, Hamilton et. al 1993, 
Kansal et. al 2010, Lee et. al 2009, Santarius T et. al 2009). In a meta-analysis by Smith MD 
et. al in 2012, they reported that performing either a single or double burr-hole craniostomy 
did not provide significant differences in patient outcome improvement. In addition, many 
adjunct techniques and approaches have also been described including intra-operative 
irrigation with warm saline, frontal placement of a subdural drain, and post-operative patient 
positioning, all with the aim of reducing post-operative recurrence of CDSH (Abouzar et. al 
2007, Nakaguchi et. al 2000, Nakaima et, al 2002). At present, these are only class (II) 
evidences and no class (I) evidence reported in the literature on the surgical treatment of 
symptomatic CSDH as published in a meta-analsyis by Weigel and colleagues in 2003.  
 
Following surgical intervention, the majority of patients (72-90%) with CSDH will 
recover their pre-morbid functional status (Weigel et. al 2003, Borger et. al 2003,). Younger 
age patients were associated with significantly better outcomes (Ramachandran et. al 2007). 
In their retrospective analysis of outcome in 322 patients over the age of 65 years treated 
surgically for CSDH, Borger et. al in 2012 reported higher morbidity and mortality rates in 
patients between 75-95 years of age. Among the post-operative complications associated with 
CSDH surgery include tension pneumocephalus, infection of subdural space with 
development of subdural empyema, intracerebral hematoma, and seizures (Gelabert-Gonzalez 
et. al 2005). As reported in previous studies, the overall surgical morbidity with worsening 
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neurology post-operatively ranges between 4-5% (Diaz et. al 2003, Ramachandran et. al 
2007). The mortality rates in different series have been varying between 0-8% and about 10% 
of patients will have a permanent residual neurological deficit (Diaz et. al 2003, Rohde et. al 
2002).  
 
Many risk factors contributing to the recurrence of CSDH following surgical 
evacuation have been extensively studied over the last decades. Reported post-operative 
recurrence of CSDH usually varies between 5-30% (Mori et. al 2001, Nakaguchi et. al 2000). 
Besides the radiological Nakaguchi classification of CSDH (which is an independent 
predictor of recurrence), other risk factors associated with re-accumulation of CSDH includes 
advance age >70yrs, poor consciousness on admission, bleeding tendencies (anti-coagulant or 
anti-platelet use), cerebral atrophy, chronic alcohol consumption, septum or multiple 
membranes within the hematoma cavity, post-operative brain re-expansion and subdural air 
collection, and bilateral CSDH (Abouzari et. al 2007, Chon et. al 2012, Delgado et. al 2000, 
Ohba et. al 2013, Torihashi et. al 2008, Yamamoto et. al 2003). The only proven factor with 
Class I evidence yielding lower recurrence rate was reported by Santarius and colleagues in 
2009, which was the placement of  a closed drainage system following burr-hole 
craniostomy, twist-drill craniostomy or craniotomy. Recurrence of CSDH was usually found 
between 1-8 weeks after the first surgery (Mori et. al 2001). Therefore it is recommended that 
patients with CSDH be follow up for at least 2 months post-operatively to assess for possible 
hematoma recollection. The Glasgow Outcome Score is commonly used as a follow-up 
assessment tool to clinically evaluate patients post-operatively (Jennet et. al 1975). 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Surgical methods in the treatment of CSDH 
2.1.1  Burr-hole craniostomy and comparison of other techniques 
To date, there has been no standardized approach to the treatment of CSDH (Weigel 
et. al 2003). The three most well described surgical techniques for the treatment of CSDH are 
burr-hole craniostomy, twist drill craniostomy and craniotomy. The size of craniostomy 
differentiates between twist drill craniostomy (up to 5mm diameter) from burr-hole 
craniostomy (5-30mm diameter). In the mid-1920s, Putnam and Cushing reported 
comprehensively on the treatment of CSDH via craniotomy with total removal of the 
hematoma and outer neo-membranes, and recommended this as the surgical procedure of 
choice. Hence, craniotomy was advocated as the treatment of choice until the mid-1960s. In 
1964, a series with a direct comparison between craniotomy and burr-hole craniostomy 
showed better clinical outcomes and lower recurrence rate for patients in the burr-hole 
craniostomy treatment arm (Svien et. al 1964). In a separate study by Tabaddor and Shulman 
in 1977 comparing all three aforementioned techniques, they published that patients in the 
craniotomy group had the highest mortality rate and poorest outcome in comparison to those 
in the burr-hole and twist drill craniostomy groups. Two other meta-analyses comparing the 
three techniques also yield similar results, with patients in the craniotomy group 
demonstrating poorer functional outcomes (Weigel et. al 2003, Lega et. al 2010). 
Furthermore, Weigel and colleagues also concluded that burr-hole craniostomy have lower 
recurrence rate of hematoma than twist drill craniostomy.    
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 Therefore, despite the lack of class I evidence, it is widely accepted that the treatment 
of choice for CSDH was burr-hole craniostomy as it balances a low recurrence rate against 
morbidity and mortality better than twist drill craniostomy and craniotomy (Ducruet et. al 
2012, Lega et. al 2010, Weigel et. al 2003). Twist drill craniostomy is recommended for 
surgically high-risk patients as a bedside procedure under local anaesthesia whereas 
craniotomy is reserved for CSDH with significant neo-membranes (Ducruet et. al 2012).  
 
2.1.2 Number of burr-holes (single versus double) 
 At present, the number of burr holes required to optimally drain CSDH remains a 
subject of debate. There is no conclusive evidence to date to favour a single or double burr-
hole craniostomy. In a study comparing number of burr holes as an independent predictor of 
post-operative recurrence in CSDH, the authors found that patients treated with a single burr-
hole have significantly higher rate of recurrence, prolonged hospitalization, and a higher rate 
of surgical site infection (Taussky et. al 2008). Contrastingly, two other studies did not 
demonstrate any significant difference in complications, recurrence rate, mortality or 
outcome when comparing the number of burr-holes for CSDH (Han et. al 2009, Kansal et. al 
2010). In a more recent meta-analysis on 5 retrospective cohorts regarding single versus 
double burr-hole placement, it was stated that single burr-hole craniostomy was comparable 
to double burr-hole craniostomy in the treatment of CSDH. The authors also found a negative 
correlation between the number of burr-holes and the rate of recurrence as reported 
previously (Belkhair et. al 2013).  
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2.1.3 Intra-operative irrigation 
 The purpose of intra-operative irrigation of the CSDH cavity with warm saline was to 
dilute its contents and aid in the evacuation of the hematoma. However, the role of irrigation 
remains unclear and only a few papers were found to study the comparison of patients treated 
with and without intra-operative irrigation. The role of burr-hole craniostomy and irrigation 
was reported in four class III and one class II evidence publications.  
 
There was no significant difference in relation to hematoma recollection reported in 3 
of those studies when intra-operative irrigation was performed (Kuroki et. al 1994, Suzuki et. 
al 1998, Matsumoto et. al 1999). In 1993, Ram and colleagues were able to demonstrate a 
non-significant reduction in hematoma recurrence in the irrigation group. A separate report 
by Hennig et. al in 1999 found a lower rate of recurrence in patients treated with intra-
operative inflow and outflow drainage. In twist drill craniostomy however, irrigation did 
yield in a significant decrease in hematoma recurrence (Aoki et. al 1984).  The use of intra-
operative irrigation was not related to any increase in morbidity or mortality when burr-hole 
or twist drill craniostomy was performed (Aoki et. al 1984, Hennig et. al 1999).  
 
In a local study by Adam et.al which was reported in 2006, the use of intra-operative 
irrigation with warm saline as an adjunct to burr-hole craniostomy did not yield any 
significant difference in terms of clinical outcome and hematoma recurrence when compared 
with burr-hole drainage alone. However, in a recent meta-analysis by Almenawar et.al 
published in 2014, the results were contrasting when the authors revealed that irrigation of 
the hematoma cavity resulted in a significant decrease in hematoma recurrences. This finding 
was also reiterated in another meta-analysis by Liu and colleagues in September 2014, when 
they reported that intraoperative irrigation may lead to a better outcome in patients. 
13 
 
2.1.4 Closed-system drainage  
 The utility of a closed drainage system following burr-hole or twist drill craniostomy 
was the most convincing data with regards to the surgical adjuncts in treating CSDH. This 
was initially reported by Wakai et. al in 1990, when the authors noted that usage of a drain 
after burr-hole craniostomy resulted in significantly reduced rate of hematoma recurrences. In 
an earlier study, Markwalder et. al reported faster rate of recovery in patients treated with a 
closed-system drainage. The most significant change in practice came about with the level 1 
evidence publication by Santarius et. al in 2009. In their randomized controlled trial, they 
reported a significant benefit in recurrence, mortality and clinical outcome at discharge for 
patients treated with a subdural drain placement in double burr-hole craniostomy. This was 
also the only study to recommend the placement of closed-system drainage as a standard in 
the surgical management of CSDH with burr-hole craniostomy (Type A recommendation). A 
recent meta-analsyis conducted by Almenawar et.al which was published in 2014 further 
enhances the role of closed-system drain placement, which was found to significantly 
decrease the rate of hematoma recurrence. 
 
2.1.5 Drain placement 
 The placement of the drain forms the basis of this study. Much has been published on 
the placement of a closed-system drainage following a burr-hole craniostomy for the 
treatment of CSDH. The insertion of a subdural drain has been deemed safe but potential 
complications from its close proximity to the cortical brain surface such as traumatic 
contusion or hematoma with consequently worsening neurological symptoms, seizures, 
infection and subdural empyema have been reported. Therefore, a less invasive technique of 
placing a subperiosteal (subgaleal) drain was advocated by a few authors in recent years. This 
novel technique was reported in studies by Gazerri et. al and Zumofen et. al, both of which 
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yielded similar rates of recurrence and complications when compared with placement of 
subudural drain. In a separate study, the authors performed a retrospective direct comparison 
of subperiosteal and subdural drainage and found no significant difference in recurrence or 
complication  rates, albeit a trend towards fewer surgical complications in the subperiosteal 
group, and fewer recurrences were reported in the subdural group (Bellut et. al 2012). A 
single center prospective randomized study by Kaliaperumal et. al in 2012, which compared 
the outcomes of subdural and subperiosteal drain concluded that there was no recurrence of 
CSDH utilizing the subdural drain or subperiosteal drain following burr-hole craniostomy. In 
addition, the authors also found a statistically significant modified Rankin Score (mRS) 
measurements, with better outcomes in the subperiosteal group at 3 and 6 month follow-up.  
 
2.1.6 Anti-coagulation and anti-platelet treatment 
 There are no class I evidence comparing the outcome of patients who undergo surgery 
for the treatment of CSDH with and without reversal of oral anti-coagulants. Due to the 
increased risk of intra- and post-operative bleeding with hematoma expansion, the general 
consensus remains that of urgent reversal of oral anti-coagulants prior to surgical evacuation 
of CSDH (Ducruet et. al 2012). Rapid reversal of oral anti-coagulants is usually achieved 
with the fresh frozen plasma (FFP), recombinant Factor VIIa (rFVIIa), or prothrombin 
complex concentrate (PCC) transfusion (Lin et. al 2003, Mayer et. al 2005, Lankiewicz et. al 
2006). Intravenous vitamin K is also given as an adjuvant to FFP, PCC and rFVIIa to prevent 
a rebound change in the international normalized ratio (INR). Transfusions of these products 
have a certain degree of complications. FFP transfusion can give rise to complications such 
as transfusion related lung injury (TRALI), and also precipitate fluid overload in patients with 
renal or cardiac failure. The risk of thrombosis with consequent deep vein thrombosis and 
pulmonary embolism are related to both PCC and rFVIIa transfusion. In terms of costs, both 
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PCC and rFVIIa are considerably more expensive than FFP (Woo et. al 2012). In this study, 
due to the unavailability of rFVIIa and the high cost of PCC, FFP and vitamin K was selected 
as the reversal agents for patients on anti-coagulants. A definitive recommendation on the 
timing of resumption of oral anti-coagulant treatment in patients post-operatively has not 
been clearly defined. In general, the risk of thromboembolic events due to prolonged 
discontinuation of anticoagulation has to be balanced against the increased risk of bleeding 
due to early commencement of treatment post-operatively. In three separate studies yielding 
class (III) recommendations, the respective authors found that reinstating oral anti-coagulant 
after 72 hours of surgery was deemed safe and did not lead to a higher risk of intracranial 
bleeding post-operatively (Kawamata et. al 1995, Yeon et. al 2012, Chari et. al 2013). 
Similarly, there is no definite recommendation on the method of reversal of anti-platelet 
therapy in patients with CSDH. The most effective way is by discontinuing the drug for a 
week, which is the period of the platelet lifespan required to replace the existing 
dysfunctional platelets (Mascarenhas et. al 2012). For patients requiring urgent clot 
evacuation, the reversal of anti-platelets therapy can be done with transfusion of platelet 
concentrates or intravenous desmopressin (Rannuci et. al 2007). In our study, patients on 
anti-platelet treatment and require emergent burr-hole craniostomy, platelets were transfused 
peri-operatively.  
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2.1.7 Anti-convulsant treatment 
 The overall reported rate of seizures in patients treated surgically for CSDH ranges 
between 2.3% to 15% (Ohno et. al 1993, Ducruet et. al 2012, Ratilal et. al 2013). A higher 
post-operative seizure rate was noted in patients with unilateral and mixed-density CSDH, 
and hence AED prophylaxis was proposed in these patients (Chen et. al 2000).  Two separate 
studies reported no significant difference in rate of seizures with prophylactic administration 
of anti-epileptic drugs (AEDs), and concluded that the morbidity with AEDs far outweighs 
the benefits (Rubin et. al 1993, Ohno et. al 1993). In 1995, Sabo et. al reported a significant 
increase in morbidity and mortality in patients with CSDH presenting with new onset 
seizures, and therefore recommended the administration of AEDs for a period of six months 
following the initial presentation. In addition, another group of authors found that AED 
prophylaxis reduced the incidence of post-operative seizures in patients treated for CSDH 
(Grobelny et. al 2009). At present, recommendation for the administration of AED is for 
those presenting with seizures, while prophylactic AED is reserved for patients at high risk 
for seizures such as chronic alcohol consumption (Ducruet et. al 2012). For this study, AED 
was given only as a treatment for those presenting with seizures and not as a prophylaxis.  
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2.1.8 Volume estimation of chronic subdural hematoma 
 A simple method for the estimation of intracerebral and extradural hematoma, known 
as the XYZ/2 or ABC/2 method had been widely described previously. In 1999, Kasner et. al 
demonstrated that this method was also applicable for the calculation of acute subdural 
hematoma volume. However, the validity of this method was questionable when applied in 
the estimation of CSDH. This is due to the fact that CSDH are not always symmetric 
crescents and because of their complex neo-membrane formations, the hematoma may 
assume asymmetrical shapes such as comma, or lens on axial CT scan slices. Hence, a study 
on the value of XYZ/2 technique compared with computer-assisted volumetric analysis was 
performed by Hassan et. al in 2005. The authors defined the parameters as X; indicates the 
depth of hematoma, Y1; maximum length of hematoma on any slice, and Z1; maximum 
width of hematoma on any slice. Depth of hematoma (X value), was determined by 
multiplying the number of slices in which the hematoma was visible by the slice thickness. 
The linear distance between each corner of subdural crescent represented the length of 
hematoma (Y). When compared to the gold standard (computer-assisted volumetric analysis), 
this formula demonstrated excellent correlation, thus providing the validity of XYZ/2 formula 
in the estimation of CSDH volume (Hassan et. al 2005).  
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CHAPTER 3 
 
STUDY PROCEDURE 
 
3.1 Problem statement 
 In recent years, there has been an observed steady rise in the incidence of patients 
presenting with symptomatic CSDH, as a result of prolonged life expectancy especially in 
developing countries (Baechli et. al 2004, Gelabert-Gonzalez et. al 2005). It is also mainly a 
diagnosis mainly found in elderly patients with accompanying medical conditions which may 
contribute to its development simultaneously. To date, there are only a few class (II) evidence 
publications in the literature on the treatment of CSDH. As a general consensus, the standard 
surgical method of choice for symptomatic CSDH is burr-hole craniostomy combined with 
irrigation and placement of closed-drainage system (Lee et. al 2009, Weigel et. al 2003). In a 
randomized controlled trial by Santarius et. al in 2009, the authors concluded that placement 
of a subdural drain after burr-hole evacuation of CSDH was associated with reduced 
recurrence and mortality. More recent studies have been reported on a considerably less 
invasive method by placing a subperiosteal drain instead of the conventional subdural drain 
(Gazzeri et. al 2007, Zumofen et. al 2009, Bellut et. al 2012). This is due to the fact that 
placement of the subdural drain on the cortical brain surface could potentially give rise to 
complications such as hematoma, seizures, and surgical site infection (e.g. empyema). With a 
clear tendency towards less mortality and complications, the placement of a subperiosteal 
drain is recommended for patients with a predictable high risk of complications especially in 
patients above 80 years of age (Bellut et. al 2012).  
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3.2  Importance and Validity of Research 
 In this study, we aimed to perform a direct comparison of subdural and subperiosteal 
drainage placement for the treatment of CSDH in our local setting, to further analyze the 
recurrence rates and the overall outcomes in terms of surgical complications and mortality of 
patients. The previous study by Bellut et. al in 2012 was a retrospective analysis comparing 
the placement of subdural drainage versus subperiosteal drainage. In that study however, the 
lower rate of serious complications, mortality and post-operative seizures could not be shown 
to be statistically significant. Therefore, with a prospective study design we intended to 
collect a sample size of 30 patients in each group (power of 80%) to demonstrate the 
difference in overall outcomes and rate of hematoma recurrence (α < 0.05). The only local 
tertiary centre with neurosurgery services to practice placement of a subperiosteal drain 
following single burr-hole craniostomy is in Sarawak General Hospital. The other hospitals in 
the country practiced the standard surgical technique of a single burr-hole craniostomy and 
subdural drain placement. At present, there has been no comparative study locally, to analyze 
the overall outcome and the recurrence rate of CSDH between both surgical techniques as 
well.  
The surgical technique practiced in this study was a single burr-hole craniostomy, 
followed with irrigation and placement of the closed drainage system. As mentioned, due to 
the better outcome to complication ratio in most patients, this technique is in line with the 
standard surgical treatment of choice (Santarius et. al 2009). Single burr-hole craniostomy 
has been proven to be just as good as a double burr-hole craniostomy and is not associated 
with a higher recurrence rate of CSDH (Han et. al 2009, Kansal et. al 2010, Belkhair et. al 
2013). Similarly, intraoperative irrigation is used as an adjunct to reduce the recurrence rate 
and was not associated with any increase in morbidity or mortality (Ram et. al 1993, Hennig 
et. al 1999).  
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3.3 General Objectives 
 The main purpose of the study was to perform a direct comparison on the efficacy of 
placement of the subperiosteal drain and subdural drain, and to evaluate any differences in 
terms of surgical complications, functional outcome and mortality for the treatment of 
symptomatic CSDH. 
 
3.4  Specific Objectives 
1. To assess the general demographic characteristics of patients presenting with CSDH.  
2. To compare the pre-operative and post-operative symptoms within both groups. 
3. To compare the clinical neurological outcome of patients on admission and upon 
discharge based on the Markwalder grad within both groups. 
4. To compare the post-operative hematoma size/volume based on CT scans between the 
two groups. 
5. To compare the overall surgical complications between the two study groups. 
6. To compare the functional outcome of patients based on the Glasgow Outcome Score 
at discharge and at 3 months follow-up between the two study groups. 
7. To compare the mortality rate between the two study groups. 
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3.5  Research Questions 
1. Is there a significant difference in terms of pre-operative and post-operative 
symptoms within both groups? 
2. Is there a significant difference in the Markwalder grade of patients within both 
groups on admission and upon discharge? 
3. Is there a significant difference in the pre-operative and post-operative hematoma size 
and volume between the two groups? 
4. Is there a significant difference in the surgical complications between the 
subperiosteal and subdural drain groups? 
5. Is there a significant difference in the functional outcome, based on the Glasgow 
Outcome Score of patients upon discharge and during 3 month follow-up between the 
two groups? 
6. Is there a significant difference in terms of mortality between the two groups? 
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CHAPTER 4 
MATERIALS AND METHODS 
 
4.1 Research Design 
 This was an interventional prospective comparative study in a double centre to 
evaluate the efficacy of the subperiosteal drain placement compared with subdural drain 
placement and to demonstrate any differences in terms of overall surgical complications, 
outcome and mortality. The study was approved by the Malaysian Medical Research and 
Ethics Committee (MREC). It was carried out at two different tertiary hospitals with well 
established neurosurgery services, which were Hospital Umum Sarawak (HUS) and Hospital 
Sultanah Aminah Johor Bahru (HSAJB).   
 
4.2       Research Location and Duration 
This study was performed at two different tertiary hospitals with well established 
neurosurgery services, which were Hospital Umum Kuching Sarawak (HUS) and Hospital 
Sultanah Aminah Johor Bahru (HSAJB). The duration of study was over a total of 2 years, 
spanning from January 2012 till January 2014.  
 
4.3 Surgical Techniques 
 Prior to the surgery, a proper informed consent will be taken from the patient or their 
immediate family members or caregivers, explaining in detail regarding the indications and 
risks of the study procedure. Peri-operatively, anti-coagulants and anti-platelet medications 
will be withheld before surgery, and 4 units of FFP with 10mg of intravenous (IV) vitamin K 
administered to establish normal clotting parameters. Anti-epileptic medications will only be 
given to patients who present with seizures on admission.  
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In that instance, IV Phenytoin 15-20mg/kg loading dose will be administered followed with 
an IV maintenance dose of 300mg daily. These peri-operative measures were standardized 
for both groups of patients on both of the study centres.  
 
 The standardized surgical steps involved are as described below:- 
I. The patient was given general anaesthesia during surgery. 
II. The patient was placed in a supine position with their head stabilized on a rubber 
horse-shoe ring without Mayfield head clamp fixation. 
III. The area of incision was marked and cleaned with povidone iodine and covered with 
sterile surgical drapes. 
IV. A single shot of antibiotic prophylaxis with 1.5 g of IV Cefuroxime (Zinacef; 
GlaxoSmithKline MY) and local anaesthetic agent (IV Marcain + Adrenaline) was 
administered to all patients directly before skin incision. 
V. A single burr-hole was made at the point of maximal clot thickness, with the burr-hole 
craniostomy size (measuring at least 10mm x 10mm in diameter) standardized. 
VI. The dura mater was coagulated and opened widely to the size of the burr-hole. 
VII. Intra-operative subdural irrigation was performed with body-tempered normal saline 
solution until the effluent was noted to be fairly clear and not totally removed. 
VIII. Placement of the closed-system drainage was done as practiced in each designated 
centre (subdural drain in HSAJB and subperiosteal drain in HUS).  
IX. In case of the placement of SPD system, a passive corrugated Radivac catheter was 
placed across the burr-hole beneath the galea. 
X. In case of the placement of SDD system, a Jacques catheter was negotiated through 
the burr-hole and gently placed in the subdural space. 
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XI. Either drain was pulled through a small skin incision posterolateral to the burr-hole 
and connected to a collecting system (which is passive without any suction force 
applied). 
XII. The subdural space was filled with body-tempered saline before closing the skin 
incision to minimize intracranial air collection. 
XIII. The drainage system was placed below the level of the head. 
XIV. A repeat CT brain was performed within 24 hours post-operatively 
XV. Removal of drain was done also for all patients after the repeat CT brain within 24 
hours. 
 
 
 
 
